ATL-201

N/A

Report date: 2025/11/24 17:27:18

Base Information

Drug NameATL-201

Drug Alias NameAstatine-211-J591Astatine-211-labelled-anti-PSMA monoclonal antibody J591ATL-201ATL-200

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnostics +[6]

Mechanisms of ActionIonising radiation emittersProstate-Specific Membrane Antigen modulators

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAtlab Pharma SAS

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTelix Pharmaceuticals Ltd

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A